Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Leuk Res. 2018 Jul 19;74:130–136. doi: 10.1016/j.leukres.2018.07.016

Table 3a:

Cumulative incidence over time (and 95% CI) of AML or MDS after autotransplant according to diagnosis group (with death as the competing risk)

Diagnosis

Time
post transplant
HL
(n = 915)
NHL
(n = 3,540)
PCM
(n = 4,563)
1-year 0(0–1)% 1(0–1)% 0(0–0)%
3-year 1(1–2)% 2(2–3)% 1(0–1)%
5-year 3(2–4)% 4(3–5)% 1(1–2)%
10-year 4(3–6)% 6(5–7)% 3(2–3)%